BE904223A - Association renfermant a titre de principes actifs, un analgesique central et l'adenine. - Google Patents

Association renfermant a titre de principes actifs, un analgesique central et l'adenine.

Info

Publication number
BE904223A
BE904223A BE0/216263A BE216263A BE904223A BE 904223 A BE904223 A BE 904223A BE 0/216263 A BE0/216263 A BE 0/216263A BE 216263 A BE216263 A BE 216263A BE 904223 A BE904223 A BE 904223A
Authority
BE
Belgium
Prior art keywords
adenine
analgesic
active ingredients
central analgesic
combination containing
Prior art date
Application number
BE0/216263A
Other languages
English (en)
Original Assignee
Roussel Uclaf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roussel Uclaf filed Critical Roussel Uclaf
Publication of BE904223A publication Critical patent/BE904223A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Association renfermant un analgésique central et l'adénine pour une méthode de traitement analgésique du corps humain ou animal. L'analgésique central est la morphine, la péthidine, la pentazocine, la dextromoramide. L'adénine associée à cet analgésique central, augmente son effet analgésique de manière importante.
BE0/216263A 1985-02-14 1986-02-13 Association renfermant a titre de principes actifs, un analgesique central et l'adenine. BE904223A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8502098A FR2577422B1 (fr) 1985-02-14 1985-02-14 Association renfermant a titre de principes actifs, un analgesique central et l'adenine ou l'adenosine ou l'un des analogues de l'adenosine

Publications (1)

Publication Number Publication Date
BE904223A true BE904223A (fr) 1986-08-13

Family

ID=9316262

Family Applications (1)

Application Number Title Priority Date Filing Date
BE0/216263A BE904223A (fr) 1985-02-14 1986-02-13 Association renfermant a titre de principes actifs, un analgesique central et l'adenine.

Country Status (12)

Country Link
US (1) US4760070A (fr)
JP (1) JPS61189222A (fr)
AU (1) AU593785B2 (fr)
BE (1) BE904223A (fr)
CH (1) CH667809A5 (fr)
DE (1) DE3604683A1 (fr)
FR (1) FR2577422B1 (fr)
GB (1) GB2171305B (fr)
IT (1) IT1190194B (fr)
LU (1) LU86305A1 (fr)
NL (1) NL8600381A (fr)
ZA (1) ZA86774B (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0527917B2 (fr) * 1990-05-10 2006-08-16 FUKUNAGA, Atsuo F. Adenosine et derives de adenosine utilises dans des processus d'anesthesie
US5679650A (en) * 1993-11-24 1997-10-21 Fukunaga; Atsuo F. Pharmaceutical compositions including mixtures of an adenosine compound and a catecholamine

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2610985A1 (de) * 1976-03-16 1977-09-29 Byk Gulden Lomberg Chem Fab Arzneimittel enthaltend beta-d-1 (6-amino-9h-purin-9-yl)-1-deoxyribofuranuronsaeurederivate
FR2534809B1 (fr) * 1982-10-26 1985-06-28 Roussel Uclaf Association medicamenteuse, renfermant a titre de principes actifs, un analgesique central et la vitamine b 12 ou un derive de celle-ci

Also Published As

Publication number Publication date
ZA86774B (en) 1987-04-29
DE3604683A1 (de) 1986-08-14
CH667809A5 (fr) 1988-11-15
IT1190194B (it) 1988-02-16
FR2577422B1 (fr) 1988-10-28
GB2171305B (en) 1989-01-25
JPS61189222A (ja) 1986-08-22
US4760070A (en) 1988-07-26
GB2171305A (en) 1986-08-28
IT8647656A0 (it) 1986-02-13
NL8600381A (nl) 1986-09-01
GB8603530D0 (en) 1986-03-19
LU86305A1 (fr) 1986-09-02
AU593785B2 (en) 1990-02-22
FR2577422A1 (fr) 1986-08-22
AU5367786A (en) 1986-08-21

Similar Documents

Publication Publication Date Title
EA199700213A1 (ru) Крем на водной основе для локального применения, способ его приготовления, способ лечения эректильной дисфункции у мужчин, способ лечения аноргазма у женщин, способ лечения микроваскулярных заболеваний и способ лечения ран или хирургических рассечений
DE10199020I2 (de) Galanthamin oder dessen Analoge zur Behandlung derAlzheimerschen Krankheit.
DE3588023D1 (de) Mittel zur Behandlung von Herzerkrankungen.
BE902783A (fr) Appareil et procede pour l'administration pulsee d'agents favorisant la croissance.
DE3684190D1 (de) Verwendung von tetrahydrobiopterinen zur herstellung eines medikaments zur behandlung von kinderautismus.
BG107537A (en) Method for the inhibition of human tnf alpha activity and its application
CA2285203A1 (fr) Compositions contenant de la capsaicine ou des analogues de capsaicine et un anesthesique local
DE69614375T2 (de) Dermatologische zubereitung zur behandlung von aktinischen keratosen
ATE314068T1 (de) Behandlung von seborrhoischer dermatitis
DE59605959D1 (de) Verwendung von Immunglobulin-Präparationen zur Herstellung eines Medikaments zur oralen Verabreichung zur Behandlung und Prophylaxe chronischer Schmerzzustände
SE8505920D0 (sv) New protein and its use
BE904223A (fr) Association renfermant a titre de principes actifs, un analgesique central et l'adenine.
ES8205190A1 (es) Un procedimiento para la preparacion del acido 3,7,11,15-tetrametil-2,4,6,10-14-hexadecapentaenoico.
DE69623316D1 (de) Ctla-8 in kombination mit g-csf oder mit g-csf und il-6, und verwendung vom ctla-8 zur behandlung von infektionen
DE69330429T2 (de) Verfahren zur behandlung von haarausfall
NO179245C (no) Arylalkylestere av 4,5-dihydroksy-9,10-dihydro-9,10-diokso-2-antracenkarboksylsyre med terapeutisk aktivitet
ATE70444T1 (de) Topische methotrexatzubereitung zur behandlung hyperproliferativer epithelerkrankungen.
GEP20012377B (en) Use of Trophoblastic Beta-1 Glycoprotein for Treating Auto-Immune Diseases and Method of Treatment These Diseases
ES8706719A1 (es) Procedimiento para preparar un derivado de trilostano
UA10200A (uk) Спосіб лікування хронічного алкоголізму а.т.філатова - с.і.жижильова
FR2368269A1 (fr) Compositions en vue d'applications capillaires
ATE153533T1 (de) Zubereitungen, die acyclovir-ähnliche verbindungen und 2'-vinylsubstituierte nukleosidanaloge enthalten, zur behandlung viraler infektionen
UA28288A (uk) Спосіб лікування шизофренії
ATE184487T1 (de) Transdermales therapeutisches system für silatranverbindungen
RO69873A2 (fr) Methode pour le traitement des affections d'appareil locomoteur,d'appareil respirateur,du systeme nerveux periferique et des maladies gynecologiques et de peaux

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: ROUSSEL-UCLAF

Effective date: 19930228